Medicare to Negotiate Lower Prices for Weight-Loss Drugs

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The nonpartisan Congressional Budget Office projected that thanks to the negotiations, Medicare’s prices for semaglutide products “will fall substantially beginning in 2027.” That would also open the door to lower prices for competing obesity drugs like Eli Lilly’s Zepbound. Pharmacy benefit managers, which negotiate drug prices, would have more leverage to demand lower prices closer…

Read More
Online Therapy Boom Has Mainly Benefited Privileged Groups, Studies Find

Online Therapy Boom Has Mainly Benefited Privileged Groups, Studies Find

The number of Americans receiving psychotherapy increased by 30 percent during the pandemic, as virtual sessions replaced in-person appointments — but new research dampens the hope that technology will make mental health care more available to the neediest populations. In fact, the researchers found, the shift to teletherapy has exacerbated existing disparities. The increase in…

Read More